Related by context. All words. (Click for frequent words.) 87 #:#-# [023] 84 #:#-# [029] 83 Free Full Text 82 #-# Full Text 82 #:#-# [028] 82 #:#-# [035] 81 #:#-# [022] 81 J Nutr 81 #:#-# [025] 81 #:#-# [006] 80 Arch Neurol 80 Cancer Res 80 J Clin Endocrinol Metab 80 Curr Opin 80 Abstract Free Full Text 80 CrossRef Medline 80 J Am Coll 79 #:#-# [037] 79 J Clin Oncol 79 J Pediatr 79 J Am Acad 79 J Clin 79 Am J Epidemiol 79 #:#-# [033] 79 #:#-# [020] 78 Suppl 78 Int J 78 Eur J 78 J Am Soc 78 Abstract Full Text 78 Arch Intern Med 78 Cardiol 78 #:# -# [004] 78 Thromb Haemost 78 Dermatol 78 #:#-# [016] 77 #:#-# [019] 77 Arch Dermatol 77 Am J Clin 77 Obstet Gynecol 77 Psychiatric Services #:#-#,# 77 Nutr 77 FASEB J. 77 #:#-# [024] 77 Nat Genet 77 EMBO J. 76 #:#-# [001] 76 #:#-# [002] 76 Environ Health Perspect 76 Nephrol 76 J Neurosurg 76 Suppl. 76 Br J Haematol 76 Ann Oncol 76 Crit Rev 75 N Engl J 75 suppl. 75 #:#-# [027] 75 #:#-# [007] 75 Mol Cell 75 Antiviral Therapy 75 Psychol 75 Pediatr 75 #-# Abstract Full [002] 75 Endocrinol 75 J Natl Cancer Inst 75 Neurol 75 Immunol 75 Br J 75 J Allergy Clin 75 Ann Rheum Dis 74 Ann Intern Med 74 #:#-# [030] 74 Crit Care Med 74 Orthop Surg 74 Anesth 74 #-# Abstract Full [001] 74 Nat Rev 74 suppl 74 #:#-# [040] 74 #:# -# [005] 74 Am J Cardiol 74 Neurosci 74 doi #.# 74 J Consult Clin 73 Proc Natl Acad Sci 73 Ann Emerg Med 73 #:#-#,# [003] 73 Pathol 73 JAMA #:#-# 73 Arthritis Rheum 73 Psychiatry #:#-# [002] 73 doi #.#/fj.#-# 73 Arch Gen Psychiatry 73 #:#-# [032] 73 Oncol 73 PMID # [002] 73 #:#-# [018] 73 J Rheumatol 73 Toxicol 73 ANN INTERN MED 73 Infect Dis 73 abstr 73 Child Adolesc Psychiatry 73 Ophthalmol 73 J Child Adolesc 73 Eur J Endocrinol 73 Am J Respir 73 #:#-# [003] 73 Surg 73 Am J Pathol 72 Annu Rev 72 #:#-#,# Medline 72 #:# -# [006] 72 Kidney Int 72 Diabet Med 72 Rehabil 72 Scand J 72 Biol Phys 72 Neurosurg 72 Crit Care 72 Clin J 72 #:# -# [002] 72 J Foot Ankle 72 J Med 72 Soc Sci Med 72 Eur Urol 72 Nat Clin Pract 72 Eur J Cancer 72 Br J Cancer 72 Rheumatol 72 Cochrane Database Syst Rev. 72 Clin Oncol 72 Int J Radiat Oncol 72 Psychopharmacol 72 J Neurosci 72 Physiol 71 Am J Geriatr 71 J Biol Chem 71 Psychiatry #:#-# [001] 71 Clin Chem 71 Clin Endocrinol 71 Syndr 71 Biol 71 Services #:#-#,# Abstract 71 Obes Res 71 Disord 71 #:#-#,# CrossRef Medline [002] 71 #:# -# [003] 71 #:#-# [010] 71 Int J Cancer 71 Biol Psychiatry 71 Gynecol 71 #:# -6 71 doi #.#/S#-# 71 Psychiatry #:#-# [003] 71 J Urol 71 #:#-#,# [002] 71 Proc Am Soc 71 Cardiovasc 71 General Psychiatry #:#-#,# 71 Br J Psychiatry 70 J Exp Med 70 Pract 70 Prolongs Survival 70 See CLINICAL PHARMACOLOGY 70 Lancet Oncol 70 Diabetologia 70 Am J Obstet 70 Ann Surg 70 #:# -# [001] 70 Nephrol Dial Transplant 70 Int J Epidemiol 70 Eur Respir J 70 Relapsing Multiple Sclerosis 70 Am J Physiol 70 J Cataract Refract 70 Endocrinol Metab 70 Gynecol Oncol 70 Oral Fingolimod 70 Arch Pediatr Adolesc Med 70 #:#-# [014] 70 Cancer Epidemiol Biomarkers Prev 70 Br J Dermatol 70 Abstract Number 70 J Clin Psychiatry 70 Microbiol 70 Psychiatry Res 70 Nat Med 70 Eur Heart 70 Sports Exerc 70 Epidemiol 70 Cell Biol 69 Cancer Incidence Mortality 69 Meta Analysis 69 Urol 69 Arch Dis Child 69 Arch Surg 69 J Clin Invest 69 CD# [004] 69 Gastroenterol 69 Arch Facial Plast 69 e# [005] 69 DOI #.#/S#-# 69 Clinical Outcome 69 Genome Res 69 Am J Gastroenterol 69 Arch Ophthalmol 69 Clin 69 Article PubMed ChemPort 69 J Shoulder Elbow 69 Controlled Trial 69 S1 S# [002] 69 Onc 69 Phys Ther 69 #:# -8 69 Int J Obes Relat 69 Acta Paediatr 69 Epub ahead 69 J Clin Epidemiol 69 J Pathol 68 s# s# 68 Engl J Med 68 Mg Uk 68 Novel Oral 68 Heterozygous Familial Hypercholesterolemia 68 Hematol 68 Exp Clin 68 #:#-# [005] 68 Cochrane Database Syst Rev 68 Dtsch Arztebl Int 68 Psychiatry Clin Neurosci 68 J Acquir Immune Defic 68 Clin Cancer 68 doi #.#/j.#-#.#.#.x 68 J Psychiatry 68 Phytochemistry 68 #S #S [003] 68 Clin Infect Dis 68 J Appl 68 See WARNINGS 68 Schizophrenia Bulletin 68 Pharmacother 68 Am Soc Nephrol 68 Slow Progression 68 gene polymorphism 68 Preclinical Study 68 Complicated Skin 68 J Virol 68 J Nerv Ment Dis 68 pp #-# 68 Radiol 68 Mol Psychiatry 67 Biochem Pharmacol 67 Endometrial 67 Clinical Practice Guideline 67 Prevalence Worldwide 67 Eur Arch 67 Psychol Med 67 J Cardiovasc 67 S# S# [001] 67 Attenuates 67 suppl #S 67 Cell Physiol 67 Acta Psychiatrica Scandinavica 67 #:#-# [009] 67 Mg Usa 67 DOI #.#/hep.# 67 Neurotology 67 Systematic Review 67 Adjunctive 67 Novel Inhibitor 67 Inflammatory Markers 67 J Immunol 67 Autoantibodies 67 Therapeutic Advances 67 J Biol 67 Patients Receiving 67 Thromboembolic 67 Metab 67 Parathyroid Hormone 67 Adenoma 67 Cardiovascular Interventions 67 Prostatic 67 Diagn 67 Vitro Activity 67 Pharmacodynamics 67 Hypertens 67 Metab Disord 67 Lymphocytic 67 Subtypes 67 Biotechnol 67 myelodysplastic myeloproliferative diseases 66 e# e# [003] 66 Diabetes Res Clin 66 Psychiatr 66 J Clin Psychopharmacol 66 Thrombotic 66 Cogn 66 :# [004] 66 Vaccine Immunology 66 Patients Treated With 66 Addict Behav 66 Mouse Model 66 Mol Med 66 Dent Res 66 Hemodialysis Patients 66 alfuzosin 66 imipramine Tofranil 66 Progenitor Cells 66 Interv 66 Osteoporos Int 66 Pharmacol 66 elevated transaminases 66 Health Syst Pharm 66 Fondaparinux 66 Neurochemistry 66 J Neurol 66 Psychosom Med 66 Treating Chronic 66 FRACP 66 Chronic Renal Failure 66 Heart Circ Physiol 66 Infect Control 66 prucalopride 66 Oncogene 66 Psychiatric Epidemiology 66 Orthostatic Hypotension 66 Arterial Disease 66 J Antimicrob Chemother 66 Nebulized 66 Chronic Bronchitis 66 Clin Pharmacol Ther 66 Randomized Controlled Trials 66 Excretion 66 CLINICAL STUDIES 66 pp. #-# [005] 66 Lowers Risk 66 Chronic Heart Failure 66 Benign Prostatic Hyperplasia 66 Antitumor 66 Adjunctive Therapy 66 ergot derivatives 66 I# I# [002] 66 treat benign prostatic 66 liposome injection 66 World J Gastroenterol 66 Occup 66 J Affect Disord 66 Motility 66 Article PubMed ISI ChemPort 66 Cardiac Rhythm 66 Bacteremia 65 Adjuvant Chemotherapy 65 Nonalcoholic Fatty Liver Disease 65 Clinical Psychiatry 65 Peripheral Arterial 65 Mayo Clinic Rochester MN 65 Double Blind Randomized 65 lexidronam injection 65 Generalized Anxiety Disorder 65 MR Angiography 65 Antimicrobial Chemotherapy 65 essential thrombocythemia ET 65 e# [001] 65 Diabetic Neuropathy 65 Am Fam Physician 65 Primary Hypercholesterolemia 65 Surgical Treatment 65 Hematological 65 murine model 65 Cancer J Clin 65 Antigen Specific 65 HLA DRB1 * 65 pan HDAC inhibitor 65 Severe Sepsis 65 Antiplatelet 65 Systemic Sclerosis 65 Randomized Study 65 Rheumatoid 65 Clinical Evaluation 65 Oral Presentation # 65 PMID # [001] 65 Polymorphisms 65 Prognostic significance 65 Dendritic Cells 65 IN PATIENTS WITH 65 Suicidality 65 Exacerbation 65 Prospective Multicenter 65 Pediatric Endocrinology 65 Prenatal Diagnosis 65 Novel Small Molecule 65 Patients Undergoing 65 Demonstrates Sustained 65 candesartan cilexetil 65 Meets Primary Endpoint 65 Health Aff Millwood 65 Phase 2b Clinical Trial 65 Prospective Randomized Trial 65 Multicenter Study 65 Pooled Analysis 65 Intern Med 65 ß blockers 65 #:#-# [038] 65 Study Evaluating 65 Miner Res 65 Psychopharmacol Bull 65 Physiology Seminar 65 zoledronate 65 Intracerebral 65 Thiazolidinediones 65 journal Arteriosclerosis Thrombosis 65 Molecular Cancer 65 Tyrosine Kinase Inhibitor 65 Psychosomatic Research 65 Neuroepidemiology 65 Adjuvant Treatment 65 Orthopsychiatry 65 Non Alcoholic Steatohepatitis 65 Neoplasms 65 Pharmacologic 65 abacavir Ziagen 65 Late Breaker 65 Non Alcoholic Fatty 65 unfractionated heparin UFH 65 Thromboembolism 65 J Clin Periodontol 65 Adiposity 65 IND Application 65 DOI #.#/s#-#-#-# 65 Heart Failure Patients 65 R Saizen R 65 Pharmacokinetics PK 65 deep venous thromboses 65 Acta Psychiatr Scand 65 Invasive Fungal Infections 65 NMIBC 65 HBeAg + 64 journal Anesthesia 64 journal Psychotherapy 64 Modulates 64 Bone Metastases 64 Vasc 64 Psychosomatics 64 Geriatr 64 Int Clin Psychopharmacol 64 Papillary 64 Placebo Controlled Trial 64 Subgroup Analysis 64 Prospective Randomized 64 :# [003] 64 MB BCh 64 Clinical Trial Results 64 Completes Patient Enrollment 64 somatostatin analog 64 Immune Responses 64 Cell Proliferation 64 Inflammatory Arthritis 64 Peptic Ulcer 64 deoxy 64 Postdoctoral Position 64 Demonstrates Significant 64 Joint Surg Am 64 INSPIRE Trial Phase III 64 #.#/pnas.# 64 Interferon Beta 64 Aneurysm Repair 64 SGPT 64 #:#-# [021] 64 induce orthostatic hypotension 64 Mestinon 64 Mol Biol 64 Female Urology 64 Refractory Hodgkin Lymphoma 64 J Periodontol 64 Molecular Basis 64 dual endothelin receptor antagonist 64 CYP#A# CYP#D# 64 Myocardial Infarction Study 64 Phospholipase A2 64 Allogeneic 64 hyperphenylalaninemia HPA due 64 Percutaneous Tibial Nerve Stimulation 64 Mayo Clin Proc 64 Nat Biotechnol 64 metastatic malignant 64 Placebo Controlled Study 64 w# w# 64 Ziprasidone 64 antibody blinatumomab MT#/MEDI-# 64 Clin Nutr 64 ertapenem 64 S1 S# [001] 64 Clinical Virology 64 Renal Physiol 64 Neuropsychol 64 LANCET 64 Angiotensin Converting Enzyme 64 J. Clin 64 Hepatotoxicity 64 Prophylactic Treatment 64 Bioorganic 64 Levels Linked 64 Eur J Neurol 64 Kinase Inhibitor 64 CLINICAL PHARMACOLOGY 64 Anticancer Drugs 64 Previously Treated 64 Antitumor Activity 64 Schizophr Res 64 Am J Ophthalmol 64 Tocopherol 64 II Clinical Trial 64 Treated Patients 64 Bronchiectasis 64 Chronic Hepatitis C 64 Overactive Bladder 64 reuptake inhibitor 64 Slows Progression 64 Carotid Stenting 64 erythematosus 64 #:#-#,# CrossRef Medline [001] 64 e# e# [001] 64 Differential Diagnosis 64 Mycophenolate Mofetil 64 J Infect Dis 64 MD FRCS 64 p.# [001] 64 Muscle Cells 64 Oral Presentation 64 J Nucl Med 64 Prognostic Value 64 Arch Otolaryngol Head 64 Hepatocellular 64 Cerebrovascular Diseases 64 Tumor Progression 64 Relapsed Refractory 64 NIDDM 64 Atypical Hemolytic Uremic Syndrome 64 Tumor Angiogenesis 64 Neoplasia 64 Demonstrates Efficacy 64 Neuroradiology 64 Patency 64 Author Affiliations Division 64 Natalizumab 64 WEB OF SCIENCE 64 Secretase 64 Coronary Angiography 64 Immunologic 64 Teratology 64 Sevelamer 64 Lymphoid 64 Upregulation 64 Reprod 64 Cannabinoid 64 moderate hepatic impairment 64 Oligonucleotides 64 Safinamide 64 Dehydrogenase 64 Prognostic Factors 64 Lupus Nephritis 64 Nucleic Acids Res 64 Studien 64 Basal Cell 64 Hyperlipidemia 64 experimental allergic encephalomyelitis 64 BMC Musculoskeletal Disorders 64 Comorbidities 64 Captopril 64 Respiratory Disorders 64 Red Hat alert RHSA 64 Paediatr 64 Toxicological Sciences 64 Observational Study 64 DOI #.#/science.# 64 bone marrow reticulin deposition 63 Intra arterial 63 Atomoxetine 63 Systemic Lupus Erythematosus 63 Arteriosclerosis 63 Article PubMed 63 Carcinomas 63 leiomyomas 63 Reduces Mortality 63 Linezolid 63 Antitumor activity 63 Anesth Analg 63 Controlled Study 63 Soft Tissue Sarcoma 63 Sipuleucel T 63 Neurology Neurosurgery 63 antidiabetic drug 63 Dis Colon Rectum 63 FDA Approvals 63 #:# -9 63 subcutaneous immunoglobulin 63 Dose Ranging Study 63 Maleate 63 headache abdominal pain 63 Myeloid 63 infliximab etanercept 63 Critical Reviews 63 Maven Semantic 63 Combination REOLYSIN R 63 FDA APPROVES 63 Acute Renal Failure 63 pioglitazone hydrochloride 63 MassGeneral Institute 63 Behav 63 Cypher Sirolimus 63 Parkin DM 63 Diabetology 63 Streptococcus agalactiae 63 Fungal Infections 63 Ann Pharmacother 63 protein tyrosine phosphatase 1B 63 Conjugated 63 NSABP B 63 Inhibits 63 Intervention Effectiveness 63 Clinical Efficacy 63 Predict Response 63 Testis 63 DOI #.# 63 Diagnostic Criteria 63 cis retinoic acid 63 Postprandial 63 Inj 63 Inflammatory Diseases 63 pT2 63 Gastric Cancer 63 TNF Blockers 63 Poster Presentation 63 Aust Psychiatry 63 Diabetic Foot Ulcer 63 Oxidative Stress 63 #S #S [001] 63 mediated inhibition 63 ExTRACT TIMI 63 Blood Pressure Monitoring 63 Degarelix 63 Reductase 63 Hormone Refractory Prostate Cancer 63 Valvular 63 Telithromycin 63 EuroIntervention 63 Schizophr Bull 63 Randomized Phase II 63 Node Positive 63 Novel Treatments 63 Cell Mol Physiol 63 Peginterferon Alfa 2a 63 Is Well Tolerated 63 Drug Candidate 63 Polymorphism 63 ISSN #-# 63 Current Controlled Trials 63 Myelodysplastic Syndrome MDS 63 Cytochrome P# 63 MD MHSc 63 Single Dose 63 Proves Effective 63 Preclinical Models 63 Phase 2a Trial 63 Inflammatory Pain 63 Chicago Multidisciplinary Symposium 63 Increased Mortality 63 e mail mediarelations@jama-archives.org 63 Ostomy Wound Management 63 Autoimmune Diseases 63 Randomized Double Blind Placebo 63 Renal Insufficiency 63 Potent Antiviral Activity 63 Pediatric Gastroenterology 63 transthyretin TTR mediated amyloidosis 63 reflux esophagitis 63 FASEB J 63 paroxetine sertraline 63 Contrast Agent 63 Cytotoxic T 63 SPRYCEL ® 63 HeFH 63 Critically Ill Patients 63 Demonstrates Positive 63 interferon gamma 1b 63 aripiprazole Abilify 63 Hosp Epidemiol 63 Oncologic 63 Clinical Psychopharmacology 63 Dual Antiplatelet Therapy 63 nicardipine 63 Randomized Double blind 63 #p# [003] 63 Hum Reprod 63 PROCTOCORT R 63 FUENTE 63 Lung Injury 63 Susceptibility Testing 63 PEDIATRICS 63 cefotaxime 63 Renal Artery 63 Nucl Med 63 Molecular Endocrinology 63 Transdermal Patch 63 Community Acquired Pneumonia 63 Postmenopausal Women 63 Phase Ib Clinical Trial 63 Randomized Comparison 63 Androgen Receptor 63 Clostridium difficile Infection 63 Danazol 63 Bone Marrow Transplantation 63 Skin Disorders 63 Haemostasis 63 Beta Blocker 63 Extracellular Matrix 63 Significantly Improves 63 Stress Incontinence 63 Bone Metabolism 63 Skeletal Muscle 63 Neuroimmunology 63 Mil Med 63 #:# -7 63 Intracoronary 63 Acquired Immune Deficiency Syndromes 63 Estrogen Receptor 63 Research www. elsevier.com 63 humanized monoclonal 63 Cell Mol Biol 63 doi #.#/s#-#-#-# 62 Therapeutic Effects 62 Leukemias 62 nondiabetic patients 62 Microvascular 62 #.#mg/dL 62 CNS Disorders 62 Acta Scandinavica 62 Trandolapril 62 Cellular Immunology 62 Newly Diagnosed Multiple Myeloma 62 glucocorticoid induced osteoporosis 62 M. EVELD 62 Mylan Receives Approval 62 QT Prolongation 62 Shows Promise Against 62 Catheter Associated 62 Hypertrophic 62 Hsp# Inhibitor 62 이다 62 procainamide 62 Physician Insights 62 Phase 2b Trial 62 number NCT# ClinicalTrials.gov 62 Dose Response 62 Initiate Phase 62 Fibrinogen 62 hydroxylase 62 Virus Infection 62 EMRG VIO 62 Phase IIa Clinical Trial 62 RECORD1 62 Neuropsychologia 62 Levaquin levofloxacin 62 Late Onset 62 Phytotherapy Research 62 Recombinant Human 62 Nilotinib 62 antibiotics metronidazole 62 Kidney Function 62 Liver Failure 62 JAMA. 62 Hemorrhagic 62 recurrent glioblastoma multiforme 62 Clin Psychol Rev 62 #:# [013] 62 nitrofurantoin 62 FRCPath 62 Reproductive Toxicology 62 Clinical Neurophysiology 62 Small Intestine 62 NICE Recommends 62 Shows Efficacy 62 benzoic acid hyoscyamine sulfate 62 familial amyloidotic polyneuropathy FAP 62 Regul Integr Comp Physiol 62 Hepatic Encephalopathy 62 Endocarditis 62 Initiates Clinical Trial 62 Trial Evaluating 62 Phase 2a Clinical Trial 62 J Psychosom Res 62 Arterioscler Thromb Vasc Biol 62 Paroxysmal Nocturnal Hemoglobinuria 62 Subclinical 62 Protease Inhibitors 62 Breast Carcinoma 62 FIND THIS STUDY 62 Cardiovascular Outcomes 62 neutropenia dehydration dyspnea 62 Prognostic Significance 62 atherosclerotic vascular disease 62 Hum Mol Genet 62 aspartate aminotransferase 62 bioavailable testosterone 62 Neuropharmacology 62 Luvox fluvoxamine 62 J Endocrinol 62 Comorbidity 62 Orally Active 62 Istituto di e 62 Patient Tables Computerized 62 Antihypertensive 62 Mol Cell Biol 62 ALN HPN 62 Monopril 62 Fluvastatin 62 AVAPRO 62 uricase 62 Conjugate 62 Improved Survival 62 Randomized Phase 62 Treat Parkinson Disease 62 By Robert Preidt 62 #S #S [002] 62 liposomal amphotericin B 62 J Cereb Blood 62 HLA DR4 62 Develops Novel 62 Cognitive Impairment 62 Polyneuropathy 62 Lancet Device Reagent 62 receiving prophylactic anticoagulation 62 BPS IC 62 Fulvestrant 62 Chronic Sinusitis 62 interleukin IL -6 62 Neurotoxicity 62 arsenic trioxide injection 62 Decitabine 62 Med Assoc 62 Pivotal Phase III 62 Escherichia coli Klebsiella pneumoniae 62 Histopathological 62 Clinical Trial Data 62 Beta Amyloid 62 Hematologic Oncology 62 Endometrial Cancer 62 Safety Tolerability 62 Proc Am 62 heFH 62 upregulates 62 Tumor Response 62 Protease Inhibitor 62 Nephropathy 62 SSc 62 complement inhibitor eculizumab 62 Cutaneous 62 Inactivation 62 DOI #.#/j.#-#.#.#.x 62 Tegretol carbamazepine 62 See CONTRAINDICATIONS 62 ACTIQ ® 62 5 Fluorouracil 62 Reminyl galantamine 62 Drug Shows Promise 62 Elderly Patients 62 은 62 Pharmacoepidemiology 62 Phenotype 62 Cilostazol 62 REMINDER ORLive Presents 62 Systemic Lupus Erythematosus SLE 62 를 62 diarrhea predominant irritable 62 Severe Asthma 62 Allergic Rhinitis 62 Polymerase Inhibitor 62 vol.# 62 Histologic 62 Teva Provides Update 62 Long Term Efficacy 62 CALGB # [002] 62 Asymptomatic 62 Clinical Practice Guidelines 62 cause cardiac channelopathies 62 Nucleoside 62 haloperidol Haldol 62 Nonalcoholic Steatohepatitis 62 Ischemic 62 syngeneic 62 Posttraumatic stress disorder 62 Symptom Management 62 Hyg 62 Advanced Melanoma 62 Histological 62 Pathology Microbiology 62 Chronic Myelogenous Leukemia 62 PEGylated anti 62 vapreotide acetate 62 bacterial vaginosis BV 62 undergoing radical cystectomy 62 Lipid Metabolism 62 mL/min/#.# m 2 62 Renal Cancer 62 BERKELEY CA UroToday.com 62 LENALIDOMIDE 62 JBJS 62 itraconazole Sporanox 62 Br J Surg 62 Orthop 62 Fetal Neonatal Ed 62 Study Demonstrates 62 oral diclofenac 62 Bipolar Disorders 62 cisplatin gemcitabine 62 Aggressive Reduction 62 Cardiovascular Pharmacology 62 GW# [003] 62 Metabolic Endocrinology 62 Infarct 62 Reperfusion Injury 62 Pediatric Oncology Branch 62 Receives Orphan Drug Designation 62 Neuroreport 62 Successfully Treated 62 irreversible inhibitor 62 Randomized Controlled 62 CARDIOVASCULAR 62 Amniotic Fluid 62 Stent Restenosis 62 Dysplasia 62 Interferon beta 1b 62 thyrotropin 62 Diabetic Nephropathy 62 Hum Genet 62 Peginterferon 62 MOTOGP +#.# [001] 62 Therapeutic Competitors Report 62 J Hum Genet 62 Advanced Renal Cell 62 restrizioni 62 Expert Opin 62 receiving INTRON 62 Monocyte 62 Menopausal Symptoms 62 Randomized Controlled Trial 62 ^ sup #m 62 Knee Osteoarthritis 62 PENTASA 62 것이다 62 Med Sci 62 Acute Treatment 62 Fracture Risk 62 cytomegalovirus infection 62 Cardiac Failure 62 PEG IFN 62 Zorbtive TM 62 Pathophysiology 62 Pediatric Patients 62 Pegylated Interferon 62 glucocorticoid induced 62 By JENNIFER LEARN 61 taxane resistant 61 Tigecycline 61 Improves Outcomes 61 Hypoparathyroidism 61 Anticancer Agents 61 Biological Therapy 61 novel VDA molecule 61 chronic eosinophilic leukemia 61 Renal Cell Carcinoma 61 Triglyceride 61 surgically resected 61 Artificial Organs 61 #/#mg 61 Hormone Receptor Positive 61 Phase IIb Clinical Trial 61 Immunoassays 61 Diagnostic Tests 61 Glatiramer Acetate 61 Malignancies 61 Invasive Breast Cancer 61 Drug Prevents 61 Analgesia 61 selective modulator 61 promoter polymorphism 61 Gastrointest Liver Physiol 61 Oral Formulation 61 Emerg Med 61 linezolid resistant 61 Systematic Reviews 61 Successfully Treats 61 Experimental Allergy 61 Peripheral Blood 61 J Invest Dermatol 61 Mouse Models 61 idiopathic myelofibrosis